John R Baldwin

Title: The Innovations of John R. Baldwin

Introduction

John R. Baldwin is a notable inventor based in Kalamazoo, MI (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of innovative dosage forms. His work has led to advancements that benefit patients requiring specific medication regimens.

Latest Patents

One of Baldwin's key patents is for a once-daily dosage form of pramipexole. This orally deliverable pharmaceutical composition includes a therapeutically effective amount of pramipexole or a pharmaceutically acceptable salt thereof, along with at least one pharmaceutically acceptable excipient. The composition is designed to exhibit a controlled release profile, ensuring that no more than about 20% of the pramipexole is dissolved within the first two hours after administration. This innovation is particularly useful for patients who require a dopamine receptor agonist, allowing for effective treatment with a single daily dose.

Career Highlights

Baldwin has been associated with Pharmacia Corporation, where he has utilized his expertise to develop groundbreaking pharmaceutical solutions. His work has not only contributed to the company's portfolio but has also had a lasting impact on patient care in the field of neurology.

Collaborations

Throughout his career, Baldwin has collaborated with esteemed colleagues such as Gerard M. Bredael and Mark J. Heintz. These partnerships have fostered an environment of innovation and have led to the successful development of new pharmaceutical products.

Conclusion

John R. Baldwin's contributions to the pharmaceutical industry, particularly through his patent for pramipexole, highlight his role as an influential inventor. His work continues to pave the way for advancements in medication delivery systems, ultimately improving patient outcomes.